Increased 30-day readmission rate after craniotomy for tumor resection at safety net hospitals in small metropolitan areas.


Journal

Journal of neuro-oncology
ISSN: 1573-7373
Titre abrégé: J Neurooncol
Pays: United States
ID NLM: 8309335

Informations de publication

Date de publication:
May 2020
Historique:
received: 19 02 2020
accepted: 18 04 2020
pubmed: 30 4 2020
medline: 24 3 2021
entrez: 30 4 2020
Statut: ppublish

Résumé

Unplanned readmission of post-operative brain tumor patients is often attributed to hospital and patient characteristics and is associated with higher mortality and cost. Previous studies demonstrate multiple patient outcome disparities in safety net hospitals (SNHs) when compared to non-SNHs. This study uses the Nationwide Readmissions Database (NRD) to determine if initial brain tumor resection at SNHs is associated with increased 30-day non-elective readmission rates. Patients with benign or malignant primary or metastatic brain tumor undergoing craniotomy for surgical resection were retrospectively identified in the NRD from 2010 to 2014. SNHs were defined as hospitals with Medicaid and uninsured patient burden in the top quartile. Descriptive and multivariate analyses employing survey-adjusted logistic regression evaluated patient and hospital level factors influencing 30-day readmissions. During the study period, 83,367 patients met inclusion criteria. 44.7% of patients had a benign tumor, and 55.3% had a malignant tumor. Secondary CNS neoplasm (5.99%), post-operative infection (5.96%), and septicemia (4.26%) caused most readmissions within 30 days. Patients had increased unplanned readmission rates if they underwent craniotomy for tumor resection at a SNH in a small metropolitan area (OR 1.11, 95% CI 1.02-1.21, p = 0.01), but not at a SNH in a large metropolitan area (OR 0.99, 95% CI 0.93-1.05, p = 0.73). This finding may reflect differences in access to care and disparities in neurosurgical resources between small and large metropolitan areas. Inequities in expertise and capacity are relevant as surgical volume was also related to readmission rates. Further studies may be warranted to address such disparities.

Identifiants

pubmed: 32346836
doi: 10.1007/s11060-020-03507-7
pii: 10.1007/s11060-020-03507-7
pmc: PMC8501910
mid: NIHMS1745003
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

141-154

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001855
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1TR000130
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1TR001855
Pays : United States
Organisme : Southern California Clinical and Translational Science Institute
ID : Research Career Development Award
Organisme : NCATS NIH HHS
ID : UL1 TR000130
Pays : United States

Références

J Neurooncol. 2018 Sep;139(2):389-397
pubmed: 29691776
Circ Cardiovasc Qual Outcomes. 2010 Sep;3(5):459-67
pubmed: 20736442
J Neurosurg. 2019 Feb 15;132(2):491-502
pubmed: 30771780
J Neurooncol. 2013 May;112(3):393-401
pubmed: 23412775
J Clin Neurosci. 2018 Jan;47:103-110
pubmed: 29113851
World Neurosurg. 2018 Nov;119:e284-e293
pubmed: 30055361
Health Serv Res. 2015 Feb;50(1):20-39
pubmed: 24712374
Neurosurgery. 2016 Sep;79(3):356-69
pubmed: 26562821
J Healthc Qual. 2017 Jan/Feb;39(1):34-42
pubmed: 27183173
Neurosurgery. 2014 Feb;74(2):196-204; discussion 204-5
pubmed: 24176955
J Clin Neurosci. 2016 Sep;31:106-11
pubmed: 27183956
J Public Health (Oxf). 2012 Mar;34(1):138-48
pubmed: 21795302
J Neurooncol. 2018 Jan;136(1):87-94
pubmed: 28988350
J Community Health. 2013 Oct;38(5):976-93
pubmed: 23543372
Med Care. 2017 Mar;55(3):229-235
pubmed: 28060053
J Neurosurg. 2014 May;120(5):1201-11
pubmed: 24605840
Health Aff (Millwood). 2012 Aug;31(8):1739-48
pubmed: 22869652
World Neurosurg. 2019 Oct;130:e753-e759
pubmed: 31284063
JAMA Surg. 2018 Aug 1;153(8):719-727
pubmed: 29641833
J Neurooncol. 2019 Jan;141(1):159-166
pubmed: 30460629
BMC Health Serv Res. 2007 Mar 09;7:40
pubmed: 17349050
Arch Phys Med Rehabil. 2018 Jun;99(6):1060-1066
pubmed: 29274725
N Engl J Med. 2016 Apr 21;374(16):1543-51
pubmed: 26910198
BMJ Open. 2017 Jul 13;7(7):e016149
pubmed: 28710221
J Neurosurg. 2019 Feb 22;132(3):788-796
pubmed: 30797220
Cancer. 2012 Sep 1;118(17):4228-34
pubmed: 22180310
J Neurooncol. 2011 Jan;101(1):67-74
pubmed: 20495849
J Gen Intern Med. 2018 Jan;33(1):57-64
pubmed: 28971369
Cancer. 2018 Jan 1;124(1):167-175
pubmed: 28902402
Health Aff (Millwood). 2014 Aug;33(8):1314-22
pubmed: 25092831
Ann Intern Med. 2010 Jan 19;152(2):114-7
pubmed: 19949133
Neurosurgery. 2003 Jan;52(1):48-53; discussion 53-4
pubmed: 12493100
Health Place. 2015 Jul;34:207-14
pubmed: 26086690
World Neurosurg. 2018 Jun;114:e254-e266
pubmed: 29524715
J Neurosurg. 2015 Jan;122(1):61-8
pubmed: 25343184
Med Care. 2017 May;55(5):528-534
pubmed: 28319580
Cancer. 2018 Feb 15;124(4):743-751
pubmed: 29072773
Med Care. 1998 Jan;36(1):8-27
pubmed: 9431328
J Gastrointest Surg. 2019 Aug;23(8):1652-1660
pubmed: 30617771
Neuro Oncol. 2015 Oct;17 Suppl 4:iv1-iv62
pubmed: 26511214
Neuro Oncol. 2005 Jan;7(1):49-63
pubmed: 15701282
Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1723-9
pubmed: 21493013
JAMA Surg. 2019 May 1;154(5):391-400
pubmed: 30649141
J Am Coll Surg. 2014 Jan;218(1):1-7
pubmed: 24280448
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
J Neurosurg. 2015 Jul;123(1):189-97
pubmed: 25658784
N Engl J Med. 2009 Apr 2;360(14):1457-9
pubmed: 19339727

Auteurs

Neal H Nathan (NH)

Keck School of Medicine, University of Southern California, Los Angeles, CA, USA. nhnathan@usc.edu.

Michelle Connor (M)

Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Saman Sizdahkhani (S)

Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Li Ding (L)

Department of Preventative Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

William J Mack (WJ)

Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Frank J Attenello (FJ)

Department of Neurological Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH